Correction to Lancet Haematol 2025; 12: e128-37

No authors listed

Published Erratum

No authors listed. Lancet Haematol. 2025 Apr.

. 2025 Apr;12(4):e243.

doi: 10.1016/S2352-3026(25)00076-6.

No abstract available

Erratum for

Survival and quality of life in patients with lower risk myelodysplastic syndromes exposed to erythropoiesis-stimulating agents: an observational cohort study.
Garelius HKG, Bagguley T, Taylor A, Fenaux P, Bowen D, Symeonidis A, Mittelmann M, Stauder R, Čermák J, Sanz G, Langemeijer S, Malcovati L, Germing U, Sanhes L, d'Aveni M, Culligan D, Kotsianidis I, Koinig KA, van Marrewijk C, Crouch S, deWitte T, Smith A, Hellström-Lindberg E. Garelius HKG, et al. Lancet Haematol. 2025 Feb;12(2):e128-e137. doi: 10.1016/S2352-3026(24)00350-8. Lancet Haematol. 2025. PMID: 39909656 Free PMC article.